Need Help? Call 1­-866-­796-­7386
« back to stock screener

  ANIK stock: Anika Therapeutics Inc

Current Rating
Buy

Previous Rating

Strong Buy
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$22.53
Market Cap
316.2M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
1.1
P/S
2.1
Dividend %
-
P/CF
-
P/FCF
109.3
Op. Cash Flow
9K
FCF
0.2
Op. Margin
-1.50%
Net Margin
-1.10%
ROE
-0.60%
ROI
1.50%
ROA
-0.50%
EPS Growth
94.10%
Current Ratio
5.7
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Soligenix Inc (SNGX) $0.55 - - 24.8M Strong Buy
Harvard Bioscience, Inc. (HBIO) $3.82 - - 150.9M Strong Buy
Clearside Biomedical Inc (CLSD) $1.65 - - 78.2M Strong Buy
Cyclo Therapeutics Inc (CYTH) $2.10 - - 19.4M Strong Buy
Eton Pharmaceuticals Inc (ETON) $2.96 - - 76.7M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More